Literature DB >> 16191101

Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice.

Toshiharu Hayashi1, Keiko Hasegawa, Chie Adachi.   

Abstract

The role of CD4(+)CD25+ T cell in glomerulonephritis (GN) development during the preactive phase was investigated in autoimmune-prone female NZB x NZW F1 (B/WF1) mice. The administration of anti-mouse CD25+ T-cell monoclonal antibody (PC61.5) 3 days after birth induced the development of GN with an increase in IgG2a antinuclear antibody, productions of IL-6 and IFN-gamma, whereas TGF-beta1 production decreased, compared to untreated control mice. The present study results suggest that CD4(+)CD25+ T cells may, at least in part, downregulate the development of GN during the preactive phase in B/WF1 mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191101      PMCID: PMC2517438          DOI: 10.1111/j.0959-9673.2005.00438.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  27 in total

1.  Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

Authors:  Song Guo Zheng; J Dixon Gray; Kazuo Ohtsuka; Satoshi Yamagiwa; David A Horwitz
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease.

Authors:  Rebecca S McHugh; Ethan M Shevach
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

3.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

4.  Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

Authors:  H L Weiner
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

5.  Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.

Authors:  H B Richards; M Satoh; J C Jennette; B P Croker; H Yoshida; W H Reeves
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  IL-10 regulates murine lupus.

Authors:  Zhinan Yin; Gul Bahtiyar; Na Zhang; Lanzhen Liu; Ping Zhu; Marie E Robert; Jennifer McNiff; Michael P Madaio; Joe Craft
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Quantification of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  Jose C Crispin; Araceli Martínez; Jorge Alcocer-Varela
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

Review 8.  Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity.

Authors:  K Michael Pollard; Per Hultman; Dwight H Kono
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

9.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

Authors:  A N Theofilopoulos; S Koundouris; D H Kono; B R Lawson
Journal:  Arthritis Res       Date:  2001-02-14

Review 10.  The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.

Authors:  David A Horwitz; J Dixon Gray; Song Guo Zheng
Journal:  Arthritis Res       Date:  2002-03-12
View more
  15 in total

1.  Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out mice.

Authors:  Y M Wang; G Y Zhang; Y Wang; M Hu; J J Zhou; A Sawyer; Q Cao; Y Wang; G Zheng; V W S Lee; D C H Harris; S I Alexander
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

2.  Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice.

Authors:  K Ohl; A Wiener; A Schippers; N Wagner; K Tenbrock
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

3.  Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Authors:  Nicole L Regna; Cristen B Chafin; Sarah E Hammond; Abdul G Puthiyaveetil; David L Caudell; Christopher M Reilly
Journal:  Clin Immunol       Date:  2014-01-15       Impact factor: 3.969

4.  Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice.

Authors:  Toshiharu Hayashi; Ayumi Murase
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

5.  The role of CD4CD25 T cells in autoantibody production in murine lupus.

Authors:  W-T Hsu; J-L Suen; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

6.  Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.

Authors:  Chen Xing; Ning Ma; He Xiao; Xiaoqian Wang; Mingke Zheng; Gencheng Han; Guojiang Chen; Chunmei Hou; Beifen Shen; Yan Li; Renxi Wang
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

Review 7.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

Review 8.  [Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].

Authors:  K Ohl; K Tenbrock
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

Review 9.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

Review 10.  Leptin: an unappreciated key player in SLE.

Authors:  Qihang Yuan; Haifeng Chen; Xia Li; Jing Wei
Journal:  Clin Rheumatol       Date:  2019-11-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.